肺炎链球菌血清型与抗菌药物敏感性的系统综述与荟萃分析
结果显示,血清型内非敏感比例随地域和时间变化,预测定植适应性和致病性增强的因素与三类药物非敏感性风险升高相关;接种肺炎链球菌结合疫苗(PCV)后,部分非PCV血清型(如6A、6C、15A、15B/C、19A、35B)非敏感性增加,但并非普遍现象,且PCV13实施地区6A和19A的接种后非敏感性增加被减弱。
要点
- 肺炎链球菌血清型间抗菌药物非敏感性存在差异,且随地域、时间及PCV使用情况变化。
- 定植适应性和致病性增强的生物学特征与青霉素、大环内酯类及甲氧苄啶/磺胺甲噁唑非敏感性风险升高相关。
- PCV接种后部分非PCV血清型非敏感性增加,但PCV13可减弱6A和19A的接种后非敏感性增加。
核心结论
- 肺炎链球菌对青霉素、大环内酯类和甲氧苄啶/磺胺甲噁唑的非敏感性与定植时间延长及致病期间抗生素暴露机会增多相关,提示存在多条耐药选择途径。
主要发现
- 血清型内非敏感分离株比例随地域和时间变化,且在PCV使用和未使用地区均存在。
- 预测定植适应性增强和致病性增强的因素均与青霉素、大环内酯类及甲氧苄啶/磺胺甲噁唑非敏感性风险升高相关。
- PCV实施后,非PCV血清型6A、6C、15A、15B/C、19A和35B的非敏感性增加,但该模式并非普遍见于所有非PCV血清型。
- 在实施PCV13的地区,血清型6A和19A接种后非敏感性增加被减弱。
关键数值与推荐
- 评估了各血清型与青霉素、大环内酯类及甲氧苄啶/磺胺甲噁唑非敏感性的关联。
- 使用随机效应荟萃回归模型评估主要抗生素类别非敏感性患病率在不同血清型间的差异。
临床怎么用
- 临床在经验性选择抗菌药物时,应考虑肺炎链球菌血清型分布及PCV接种对非敏感性的影响。
- 持续监测PCV接种后非PCV血清型的抗菌药物非敏感性变化,有助于优化当地治疗指南。
局限性
- 原文未报告具体局限性内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pneumococcal serotypes differ in antimicrobial susceptibility. However, patterns and causes of this variation are not comprehensively understood. METHODS: We undertook a systematic review of epidemiologic studies of pneumococci isolated from carriage or invasive disease among children globally from 2000-2019. We evaluated associations of each serotype with nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole. We evaluated differences in the prevalence of nonsusceptibility to major antibiotic classes across serotypes using random-effects meta-regression models and assessed changes in prevalence of nonsusceptibility after implementation of pneumococcal conjugate vaccines (PCVs). We also evaluated associations between biological characteristics of serotypes and their likelihood of nonsusceptibility to each drug. RESULTS: We included data from 129 studies representing 32 187 isolates across 52 countries. Within serotypes, the proportion of nonsusceptible isolates varied geographically and over time, in settings using and those not using PCVs. Factors predicting enhanced fitness of serotypes in colonization as well as enhanced pathogenicity were each associated with higher likelihood of nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole. Increases in prevalence of nonsusceptibility following PCV implementation were evident among non-PCV serotypes, including 6A, 6C, 15A, 15B/C, 19A, and 35B; however, this pattern was not universally evident among non-PCV serotypes. Postvaccination increases in nonsusceptibility for serotypes 6A and 19A were attenuated in settings that implemented PCV13. CONCLUSIONS: In pneumococci, nonsusceptibility to penicillin, macrolides, and trimethoprim/sulfamethoxazole is associated with more frequent opportunities for antibiotic exposure during both prolonged carriage episodes and when serotypes cause disease. These findings suggest multiple pathways leading to resistance selection in pneumococci.
引用
- Andrejko K, Ratnasiri B, Lewnard JA, et al. Association of Pneumococcal Serotype With Susceptibility to Antimicrobial Drugs: A Systematic Review and Meta-analysis. Clin Infect Dis. 2022. PMID: 34599811. doi:10.1093/cid/ciab852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。